Evitability
Ismael calandri
2022-06-22
Clasificacion de evitabilidad
Los desconocidos son pacientes a los que les faltaba alguna de las clasificaciones y por eso no se calculo el score total
| Characteristic | N = 4911 |
|---|---|
| evitability_group | |
| no preventability | 0 (0%) |
| low preventability | 241 (67%) |
| high preventability | 120 (33%) |
| Unknown | 130 |
| 1 n (%) | |
Tabla de evitabilidad
(igual a la del paper)
Ojo, no hay sujetos con “non-evitability”
| low preventability (N=241) |
high preventability (N=120) |
Overall (N=491) |
|
|---|---|---|---|
| evitability_CE | |||
| 0 | 241 (100%) | 79 (65.8%) | 322 (65.6%) |
| 2 | 0 (0%) | 41 (34.2%) | 41 (8.4%) |
| evitability_ta | |||
| 0 | 234 (97.1%) | 88 (73.3%) | 438 (89.2%) |
| 1 | 7 (2.9%) | 9 (7.5%) | 25 (5.1%) |
| 2 | 0 (0%) | 23 (19.2%) | 27 (5.5%) |
| evitability_dlp | |||
| 0 | 143 (59.3%) | 54 (45.0%) | 289 (58.9%) |
| 1 | 98 (40.7%) | 28 (23.3%) | 150 (30.5%) |
| 2 | 0 (0%) | 38 (31.7%) | 48 (9.8%) |
| evitability_AF | |||
| 0 | 241 (100%) | 77 (64.2%) | 439 (89.4%) |
| 2 | 0 (0%) | 17 (14.2%) | 17 (3.5%) |
| 4 | 0 (0%) | 26 (21.7%) | 35 (7.1%) |
Evitabilidad por sexo
| Characteristic | Male, N = 3031 | Female, N = 1881 | p-value2 |
|---|---|---|---|
| evitability_group | 0.2 | ||
| no preventability | 0% (0 / 224) | 0% (0 / 137) | |
| low preventability | 64% (144 / 224) | 71% (97 / 137) | |
| high preventability | 36% (80 / 224) | 29% (40 / 137) | |
| evitability_total | 3.74 (2.09) | 3.28 (1.68) | 0.10 |
| 1 % (n / N); Mean (SD) | |||
| 2 Fisher's exact test; Wilcoxon rank sum test | |||
Evitabilidad por TOAST
| Characteristic | Gran vaso, N = 531 | Pequeño vaso, N = 581 | Cardioembólico, N = 831 | Otros (disección, FOP, etc), N = 681 | Indeterminado por estudios negativos, N = 2051 | Indeterminado por 2 causas, N = 221 | Indeterminado por estudios incompletos, N = 21 | p-value2 |
|---|---|---|---|---|---|---|---|---|
| evitability_CE | ||||||||
| 0 | 95% (38 / 40) | 91% (42 / 46) | 77% (46 / 60) | 96% (47 / 49) | 92% (141 / 154) | 54% (7 / 13) | 100% (1 / 1) | |
| 2 | 5.0% (2 / 40) | 8.7% (4 / 46) | 23% (14 / 60) | 4.1% (2 / 49) | 8.4% (13 / 154) | 46% (6 / 13) | 0% (0 / 1) | |
| evitability_ta | ||||||||
| 0 | 85% (45 / 53) | 88% (51 / 58) | 89% (74 / 83) | 93% (62 / 67) | 90% (185 / 205) | 86% (19 / 22) | 100% (2 / 2) | |
| 1 | 11% (6 / 53) | 6.9% (4 / 58) | 2.4% (2 / 83) | 3.0% (2 / 67) | 4.9% (10 / 205) | 4.5% (1 / 22) | 0% (0 / 2) | |
| 2 | 3.8% (2 / 53) | 5.2% (3 / 58) | 8.4% (7 / 83) | 4.5% (3 / 67) | 4.9% (10 / 205) | 9.1% (2 / 22) | 0% (0 / 2) | |
| evitability_dlp | ||||||||
| 0 | 55% (29 / 53) | 55% (32 / 58) | 65% (54 / 83) | 58% (39 / 67) | 57% (116 / 202) | 82% (18 / 22) | 50% (1 / 2) | |
| 1 | 34% (18 / 53) | 29% (17 / 58) | 30% (25 / 83) | 28% (19 / 67) | 33% (67 / 202) | 14% (3 / 22) | 50% (1 / 2) | |
| 2 | 11% (6 / 53) | 16% (9 / 58) | 4.8% (4 / 83) | 13% (9 / 67) | 9.4% (19 / 202) | 4.5% (1 / 22) | 0% (0 / 2) | |
| evitability_AF | ||||||||
| 0 | 100% (53 / 53) | 100% (58 / 58) | 47% (39 / 83) | 99% (67 / 68) | 100% (205 / 205) | 68% (15 / 22) | 100% (2 / 2) | |
| 2 | 0% (0 / 53) | 0% (0 / 58) | 16% (13 / 83) | 0% (0 / 68) | 0% (0 / 205) | 18% (4 / 22) | 0% (0 / 2) | |
| 4 | 0% (0 / 53) | 0% (0 / 58) | 37% (31 / 83) | 1.5% (1 / 68) | 0% (0 / 205) | 14% (3 / 22) | 0% (0 / 2) | |
| evitability_total | 3.05 (1.32) | 3.20 (1.54) | 5.50 (2.43) | 2.96 (1.29) | 3.05 (1.37) | 6.00 (3.03) | 3.00 (NA) | <0.001 |
| 1 % (n / N); Mean (SD) | ||||||||
| 2 Kruskal-Wallis rank sum test | ||||||||
Evitabilidad por grupo etáreo
| Characteristic | < 50yo, N = 511 | 50 to 80yo, N = 3361 | > 80yo, N = 1041 | p-value2 |
|---|---|---|---|---|
| evitability_CE | <0.001 | |||
| 0 | 100% (44 / 44) | 90% (222 / 248) | 79% (56 / 71) | |
| 2 | 0% (0 / 44) | 10% (26 / 248) | 21% (15 / 71) | |
| evitability_ta | 0.3 | |||
| 0 | 96% (49 / 51) | 89% (297 / 335) | 88% (92 / 104) | |
| 1 | 0% (0 / 51) | 5.1% (17 / 335) | 7.7% (8 / 104) | |
| 2 | 3.9% (2 / 51) | 6.3% (21 / 335) | 3.8% (4 / 104) | |
| evitability_dlp | ||||
| 0 | 60% (30 / 50) | 57% (190 / 334) | 67% (69 / 103) | |
| 1 | 26% (13 / 50) | 34% (112 / 334) | 24% (25 / 103) | |
| 2 | 14% (7 / 50) | 9.6% (32 / 334) | 8.7% (9 / 103) | |
| evitability_AF | 0.004 | |||
| 0 | 100% (51 / 51) | 90% (304 / 336) | 81% (84 / 104) | |
| 2 | 0% (0 / 51) | 3.0% (10 / 336) | 6.7% (7 / 104) | |
| 4 | 0% (0 / 51) | 6.5% (22 / 336) | 12% (13 / 104) | |
| evitability_total | 2.61 (0.87) | 3.54 (1.92) | 4.25 (2.30) | <0.001 |
| 1 % (n / N); Mean (SD) | ||||
| 2 Fisher's exact test; Kruskal-Wallis rank sum test | ||||
Algunos gráficos
